CAN DUAL ANTIPLATELET THERAPY BE GIVEN SAFELY IN THE EMERGENCY DEPARTMENT FOR ACUTE COROANRY SYNDROME?

Launched by JORDAN COLLABORATING CARDIOLOGY GROUP · Jun 18, 2025

Keywords

ClinConnect Summary

This study is looking at whether giving two blood-thinning medications, called antiplatelet drugs, right away in the emergency room (ER) is safe for people who come in with a heart problem known as acute coronary syndrome. Normally, patients get one medicine (aspirin) in the ER and a second one later in a special procedure room. This research wants to see what happens if both medicines are given early in the ER instead.

Adults who come to the hospital with types of heart attacks or unstable chest pain caused by heart problems might be eligible to take part. To join, patients must have been prescribed antiplatelet medicines during their hospital stay and agree to be contacted for check-ins up to a year after leaving the hospital. People whose chest pain isn’t related to the heart or who did not receive these medicines won’t be part of the study. Since this is a review of medical records, participants won’t have to do anything extra beyond their regular care, but their health information will be looked at to understand the safety of this early treatment approach.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients
• • Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina).
• • Antiplatelet medication (s) prescribed during index admission to hospital.
• • Willingness of the patient to be called for follow up up to 1 year after index hospitalization.
• Exclusion Criteria:
• • Non cardiac chest pain.
• • No administration of antiplatelet agents during hospitalization.
• • Refusal of contact for follow up.